PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 22400806-8 2012 Enzyme-linked immunosorbent assay results indicated that Lico A can significantly down-regulate TNF-alpha, IL-6, and IL-1beta levels in vitro and in vivo, and treatment with Lico A significantly attenuated alveolar wall thickening, alveolar hemorrhage, interstitial edema, and inflammatory cells infiltration in mice with ALI. licochalcone A 57-63 interleukin 1 beta Mus musculus 117-125 22400806-8 2012 Enzyme-linked immunosorbent assay results indicated that Lico A can significantly down-regulate TNF-alpha, IL-6, and IL-1beta levels in vitro and in vivo, and treatment with Lico A significantly attenuated alveolar wall thickening, alveolar hemorrhage, interstitial edema, and inflammatory cells infiltration in mice with ALI. licochalcone A 174-180 interleukin 1 beta Mus musculus 117-125 32965793-6 2020 In vitro, Lico A could reduce the expression of NLRP3, apoptosis-associated speck-like protein (ASC), Gasdermin D (GSDMD), caspase-1, interleukin-1beta (IL-1beta) and IL-18, which indicated that Lico A attenuates LPS-induced chondrocytes pyroptosis. licochalcone A 10-16 interleukin 1 beta Mus musculus 134-151 26552405-8 2016 Lico A also suppressed LPS-induced TNF-alpha, IL-6, and IL-1beta production both in serum and kidney tissues. licochalcone A 0-6 interleukin 1 beta Mus musculus 56-64